Yu et al.43 showed that the inhibition of calmodulin-dependent protein kinase III (eukaryotic elongation factor-2 kinase,eEF-2K) can enhance the pyroptosis-promoting effect of Doxorubicin on melanoma cell lines with high GSDME expression. The gene discussed is EEF2K; the disease is melanoma.